Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
285.60
-4.14 (-1.43%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Ligand Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $332 | Buy | Maintains | $332 | +16.25% | Aug 14, 2026 |
| Citi | Citi | Buy Maintains $387 → $390 | Buy | Maintains | $387 → $390 | +36.55% | Aug 12, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $345 | Buy | Reiterates | $345 | +20.80% | Aug 10, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 7, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Reiterates $350 → $370 | Buy | Reiterates | $350 → $370 | +29.55% | Aug 7, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $326 | Buy | Reiterates | $326 | +14.15% | Aug 7, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $358 | Buy | Reiterates | $358 | +25.35% | Aug 6, 2026 |
| Benchmark Co. | Benchmark Co. | Buy Maintains $275 → $335 | Buy | Maintains | $275 → $335 | +17.30% | Jul 16, 2026 |